|
GSK drug halves attacks in hard-to-treat asthma
Business Recorder (blog) An experimental drug for treating severe asthma from GlaxoSmithKline nearly halved the number of attacks suffered by patients with a hard-to-treat form of the disease in a clinical study, boosting hopes for its commercial success. Britain's biggest … |
View full post on asthma – Google News